These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19691790)

  • 1. Cautious comparison between East and West is necessary in terms of the serum pepsinogen test.
    Miki K; Fujishiro M
    Dig Endosc; 2009 Apr; 21(2):134-5. PubMed ID: 19691790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of Helicobacter pylori infection: Pepsinogen secretion].
    Urita Y; Miki K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():235-9. PubMed ID: 11979784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pepsinogen I, pepsinogen II, and pepsinogen I/II ratio].
    Miki K; Sasajima M; Ohtsuka T; Urita Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():741-3. PubMed ID: 16149628
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of atrophic gastritis from a serum sample.
    Sipponen P; Härkönen M; Alanko A; Suovaniemi O
    Clin Lab; 2002; 48(9-10):505-15. PubMed ID: 12389711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atrophic gastritis and Helicobacter pylori].
    Zolezzi Francis A
    Rev Gastroenterol Peru; 2002; 22(3):197-8. PubMed ID: 12378212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pepsinogen I and pepsinogen II, PG I/II ratio].
    Miki K; Sasajima M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():778-81. PubMed ID: 20960872
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pepsinogen and atrophic gastritis].
    Kawai T; Gotoda T; Moriyasu F
    Nihon Shokakibyo Gakkai Zasshi; 2013 Feb; 110(2):203-9. PubMed ID: 23381207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helicobacter pylori eradication: always?--contra].
    Arnold R
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):43-4. PubMed ID: 14703582
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
    Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
    Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers.
    Sipponen P; Graham DY
    Scand J Gastroenterol; 2007 Jan; 42(1):2-10. PubMed ID: 17190755
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum pepsinogen A in atrophic chronic gastritis and in gastric cancer: a distinctive difference in behavior?
    Perasso A; Testino G
    J Clin Gastroenterol; 1992 Sep; 15(2):164-6. PubMed ID: 1401833
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis.
    Graham DY
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1117-1118. PubMed ID: 29105138
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical and immunological criteria for evaluation of gastric mucosa in tumor and non-tumor pathology].
    Uspenskiĭ MN; Kalinovskiĭ VP; Tkachenko EI
    Vopr Onkol; 2007; 53(3):304-10. PubMed ID: 18198612
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
    Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
    Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serologic screening for preneoplastic pathology and early stomach cancer].
    Maev IV; Mel'nikova EV; Kashin SV; Nadezhin AS; Kriukova TV
    Klin Med (Mosk); 2008; 86(11):43-8. PubMed ID: 19177794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of atrophic gastritis in different populations in Siberia on medical evidence of the serological survey].
    Reshetnikov OV; Kurilovich SA; Krotov SA; Krotova VA; Bessonov PP; Vasil'ev RR; Tatarinova OV; Muchina EG
    Klin Med (Mosk); 2008; 86(7):35-8. PubMed ID: 18756745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aetiology and clinical relevance of gastric intestinal metaplasia.
    Kuipers EJ; Siersema PD
    Dig Liver Dis; 2004 Aug; 36(8):501-4. PubMed ID: 15334768
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on Helicobacter pylori research. Malignancies.
    Gasbarrini G; Genta RM; Anti M; Fox J; Caselli M; Doglioni C; Ierardi E; Masala G; Palli D; Testoni PA; Fossi S; Corinaldesi R; Cammarota G
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):621-3. PubMed ID: 9222739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.